CAITLIN ANDRYKA: Open Payments
NPI 1326449182 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 64 payments from 12 companies in 2025. Trend: 2023 $975 · 2024 $1,307 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $312 |
| Amgen Inc. | 17 | $279 |
| Janssen Biotech, Inc. | 4 | $114 |
| Mallinckrodt Hospital Products Inc. | 5 | $93 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| Lundbeck LLC | 3 | $49 |
| PFIZER INC. | 3 | $49 |
| UCB, Inc. | 2 | $37 |
| Fresenius Kabi USA, LLC | 1 | $22 |
| Aurinia Pharma U.S., Inc. | 1 | $17 |
Products named: RINVOQ, ENBREL, TREMFYA, SKYRIZI, ACTHAR, EVENITY, OTEZLA, VYEPTI.
Industry payments across AR — which companies pay providers there.
